Search

everythinglearnresearchcommunity

for

Search:↓

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

Instagram ads for skin, hair, and nail supplements often make broad health claims without clear ingredient information, and are not FDA-regulated.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Lavender is widely used for its calming effects and in beauty products, but its medical effectiveness is not fully proven and not FDA-approved.

Exosomes, tiny cell-released particles, may help hair growth, but their exact role is unclear, they're not FDA-approved, and their unregulated use can cause side effects.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Low-Level Laser Therapy is effective and safe for hair growth with minimal side effects.

Drug advertising has greatly increased, changing consumer behavior and raising concerns about its influence on healthcare and patient protection.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Low-level laser therapy is safe and can increase hair growth for male and female pattern hair loss.

Hair loss treatments include medications and new methods like low-level light therapy, which may work by boosting cell activity and blood flow.

Nanotechnology improves hair care products by enhancing ingredient stability, targeting treatment, and reducing side effects, but more research on its toxicity is needed.

Lasers might help hair growth in some alopecia cases, but more research is needed to confirm their effectiveness and safety.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Photobiomodulation may help with hair growth and wound healing, but research is inconsistent and needs better quality studies.

Bidirectional barbed sutures are effective and can reduce surgery time, with a low infection rate and potential cost savings despite being more expensive.

The ARTAS robotic system for hair restoration is efficient with fewer cuts than manual methods, but it's limited to certain hair types and can still leave scars.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Finasteride has a higher risk of reproductive side effects than minoxidil.

Newer skin resurfacing lasers reduce damage and scarring, with some approved for safe use and minimal side effects.

Most people using biotin don't see skin improvements, and it may affect lab tests, so doctors shouldn't suggest it without confirming a deficiency.

Synthetic hair fibers for hair restoration were controversial in 2009 due to health risks and lack of support from the International Society of Hair Restoration.

Laser hair transplantation can be effective but should be limited to small areas and requires more training to ensure safety and effectiveness.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.